MedPath

Ginseng

Generic Name
Ginseng
Drug Type
Biotech
CAS Number
50647-08-0
Unique Ingredient Identifier
CUQ3A77YXI

Overview

Ginseng is promoted as an adaptogen (a product that increases the body's resistance to stress), one which can to a certain extent be supported with reference to its anticarcinogenic and antioxidant properties. Ginseng is also known to contain phytoestrogens.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2015/11/11
Not Applicable
Completed
Chinese PLA General Hospital
2015/03/12
Early Phase 1
Completed
2014/08/07
Phase 2
Completed
Daegu Catholic University Medical Center
2012/10/23
Phase 2
Completed
2012/08/14
Phase 4
Completed
2011/06/17
Phase 1
Active, not recruiting
2009/11/01
Not Applicable
Completed
Frederiksberg University Hospital
2008/10/29
Early Phase 1
Completed
2008/03/10
Phase 2
Completed
2006/11/17
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
HIYA KIOGAN SILVER PILLS
N/A
N/A
N/A
8/23/1999

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ADAPTAGEN
bio active canada ltd.
02233546
Liquid - Oral
3 X
5/26/1998
PANAX GINSENG
seroyal international inc.
02233183
Globules ,  Granules ,  Capsule ,  Drops ,  Liquid ,  Tablet ,  Pellet ,  Powder - Oral
1 X
4/6/1998
GISENG GRANULE 1DH
homeocan inc.
00880310
Tablet - Oral
1 DH / DH
12/31/1990
LINGDANWANG CAPSULE
sucan international trading company
02238329
Capsule - Oral
110 MG
N/A
GINSENG-INJEEL LIQ (12D,30D,200D/1.1ML)
02058200
Liquid - Oral
12 D / 1.1 ML
12/31/1993
MEDIPLEX 655 - LIQ
mediherb inc.
02117061
Liquid - Oral
3 X / ML
12/19/1996
ENERGY ALPHA
dolisos laboratoires s.a.
02243633
Liquid - Oral
1 TM / 250 ML
2/4/2002
HOMEOPATHIC MEDICINE (S NO. 329) DPS 30C
total health centre
02077248
Drops - Oral
30 C / ML
12/31/1994
PEKANA - COMPLEX NR. 126
pekana-naturheilmittel gmbh
02232441
Globules ,  Drops - Oral
6 X
9/27/1997
PANAX GINSENG GOUTTE 4CH-30CH
dolisos laboratoires s.a.
00691453
Drops - Oral
1 DH / DH
12/31/1987

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
VITESTABLE TABLETAS
Alcor, S.L.
29191
COMPRIMIDO
Sin Receta
Not Commercialized
ARKOCAPSULAS GINSENG 300 mg CAPSULAS DURAS
Arkopharma Laboratorios S.A.
75144
CÁPSULA DURA
Sin Receta
Not Commercialized
REDSENG 300 mg COMPRIMIDOS
Korhispana S.L.
75845
COMPRIMIDO
Sin Receta
Commercialized
REDSENG 300 mg CAPSULAS
Korhispana S.L.
75841
CÁPSULA DURA
Sin Receta
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.